PMC3654325_01
PMC3654325_02
Dispersion of the anti-Toxocara IgG in serum samples of epileptic patients and healthy persons. Numbers in X-axis represent each sample (COP: cut-off point).
ERT2013-156815.001.jpg
PMC3654325_02_ERT2013-156815.001.jpg
fig1
The population seroprevalence of Toxocara antibodies was significantly higher in the epileptic patients compared with the healthy group (Figure 1).
Western blotting results for sera sample of the study population. Lane 1: reference ladder; lanes 2-4: sera testing positive by ELISA; Lane 5: Toxocara-negative control.
ERT2013-156815.002.jpg
PMC3654325_02_ERT2013-156815.002.jpg
fig2
The positive Western blotting strips indicating the presence of specific anti-Toxocara IgG in the samples showed at least two or more bands of lower molecular weight between 24 and 35 kDa (Figure 2).